About Oxidative stress-induced growth inhibitor 2
Oxidative stress-induced growth inhibitor 2 (OSGIN2) is a protein
from Homo sapiens identified by UniProt accession
Q9Y236, 505 residues long.
MolForge cross-references it against 0 known binders and
28 disease associations.
Target properties
| Protein name | Oxidative stress-induced growth inhibitor 2 |
| UniProt accession | Q9Y236 |
| Gene | OSGIN2 |
| Organism | Homo sapiens |
| Length | 505 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (28)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.38
- Crohn's disease · score 0.36
- diastolic blood pressure · score 0.26
- ulcerative colitis · score 0.17
- ankylosing spondylitis · score 0.17
- psoriasis · score 0.17
- sclerosing cholangitis · score 0.17
- inflammatory bowel disease · score 0.09
- leprosy · score 0.08
- ulcer disease · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9Y236-F1 | alphafold | PREDICTED | 87.71 | — |
Amino-acid sequence (505 residues)
MPLVEETSLL EDSSVTFPVV IIGNGPSGIC LSYMLSGYRP YLSSEAIHPN TILNSKLEEA RHLSIVDQDL EYLSEGLEGR SSNPVAVLFD TLLHPDADFG YDYPSVLHWK LEQHHYIPHV VLGKGPPGGA WHNMEGSMLT ISFGSWMELP GLKFKDWVSS KRRSLKGDRV MPEEIARYYK HYVKVMGLQK NFRENTYITS VSRLYRDQDD DDIQDRDIST KHLQIEKSNF IKRNWEIRGY QRIADGSHVP FCLFAENVAL ATGTLDSPAH LEIEGEDFPF VFHSMPEFGA AINKGKLRGK VDPVLIVGSG LTAADAVLCA YNSNIPVIHV FRRRVTDPSL IFKQLPKKLY PEYHKVYHMM CTQSYSVDSN LLSDYTSFPE HRVLSFKSDM KCVLQSVSGL KKIFKLSAAV VLIGSHPNLS FLKDQGCYLG HKSSQPITCK GNPVEIDTYT YECIKEANLF ALGPLVGDNF VRFLKGGALG VTRCLATRQK KKHLFVERGG GDGIA
Explore Oxidative stress-induced growth inhibitor 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets